Biocardia presentations at next generation cardiovascular drug development summit now available

Sunnyvale, calif., april 28, 2023 (globe newswire) -- biocardia®, inc.  [nasdaq: bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases has made available two presentations from the “next generation cardiovascular drug development summit on executing cell and gene therapy for cardiac regeneration” which took place this week on april 26-27, 2023 in boston, ma.
BCDA Ratings Summary
BCDA Quant Ranking